Blog
Health is Wealth: Direct Action Recap
18 Nov 2022, 8:16 p.m. in #insulin4all USA, Global Stories, News & Statements by T1International
Voices from around the world were part of the T1International Rally and March outside Eli Lilly on October 24th, where #insulin4all activists demanded Eli Lilly immediately lower the list price of insulin and defended the lives of those who are rationing insulin just to survive. Read more
New Rationing Data Reinforces T1International’s Call for Insulin Price Cap
17 Oct 2022, 10:11 p.m. in #insulin4all USA, Global Stories, News & Statements by T1International
A recent study of 2021 National Health Interview Survey data demonstrates what #insulin4all advocates have been saying for years: too many people are dangerously rationing insulin due to cost. While insulin costs around $6 to manufacture, three companies dominate more than 90% of the insulin market and charge around $300 for a single vial of insulin. Read more
Taking Action for Health is Wealth
13 Oct 2022, noon in #insulin4all USA, Global Stories, News & Statements by T1International
T1International’s virtual #insulin4all Summit, Health is Wealth, was held on September 24th. Thank you everyone for your participation and read our recap here! Read more
The Long Road to US Federal Insulin Law and What More Needs to be Done
16 Sep 2022, noon in #insulin4all USA, News & Statements by T1International
The journey to move towards a federal insulin price cap has been long and difficult, including challenging incremental steps. The fight for a true insulin price cap in the US continues. Read more
5 Ways To Combat Pharma Talking Points with Just the Facts
12 Aug 2022, 6 a.m. in #insulin4all USA, Global Stories, News & Statements by T1International
Misinformation about diabetes and insulin is all too regularly spread in both the media and on social platforms. In this post, we outline 5 of the most common talking points used to explain away price gouging and how we can use the facts to overcome this narrative. Read more
Calling for Empowered Implementation of Global Diabetes Coverage Targets
11 Jul 2022, 9:59 p.m. in #insulin4all USA, Global Stories, News & Statements by T1International
At the 75th World Health Assembly (WHA) of the World Health Organization (WHO), member states adopted the first ever ‘Global Diabetes Coverage Targets,’ meant to steer the course of diabetes diagnosis and treatment for the next 8 years. Read more
The Realities of Diabetes Burnout
2 Jun 2022, 7:42 p.m. in News & Statements by Konstantina Taki
For too long, understanding the precise relationship between burnout and diabetes has been a mystery, and more data must be uncovered. Working with T1International, we are sharing a new survey on the impacts and implications of burnout for those with type 1 diabetes. Read more
T1International’s 2022 Out-of-Pocket Cost Survey: An Easy Way to Advocate
27 May 2022, 9:32 p.m. in #insulin4all USA, News & Statements by T1International
Take the Survey! The survey is for individuals over the age of 18 with type 1 diabetes. A parent or caregiver can take the survey for those under the age of 18. Caregivers can also take the survey for spouses or partners. The survey is anonymous and is completely optional. Read more
Global Advocacy Success Series: Lejla Druškić, Bosnia and Herzegovina
2 May 2022, 6:48 p.m. in Global Stories, Interviews, News & Statements by Katie Souris
Lejla Druškić, Global Advocate from Bosnia and Herzegovina, is a fearless speaker. Since joining T1International’s Global Advocacy Network in July 2021, she has been an invited speaker at the 3rd annual Congress of Diabetologists and Endocrinologists of Bosnia and Herzegovina, serving as a patient representative on a panel of patients and healthcare providers. Read more
Press Release: Human Rights Watch Calls Out Unaffordable Insulin as Human Rights Crisis
12 Apr 2022, 5:21 a.m. in #insulin4all USA, News & Statements by T1International
A report from Human Rights Watch powerfully illustrates the human impact of sky-high insulin prices through the testimony of 18 insulin-dependent people living with diabetes in the United States.
Read more